Showing results (1-10 of 782) with videos related to

Sort By:
Pageof 79
Therapeutic Advances in Musculoskeletal Disease|December 2, 2014
New strategies for osteoporosis patients previously managed with strontium ranelatePeter Vestergaard
Therapeutic Advances in Musculoskeletal Disease|August 20, 2015
Belimumab in systemic lupus erythematosus: a perspective reviewJoyce S Hui-Yuen, Xiao Q Li, Anca D Askanase
Therapeutic Advances in Musculoskeletal Disease|December 2, 2015
Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implicationsNatasha Jordan, David D'Cruz
Therapeutic Advances in Musculoskeletal Disease|July 17, 2013
Bisphosphonate drug holiday: who, when and how longDima L Diab, Nelson B Watts
Therapeutic Advances in Musculoskeletal Disease|July 17, 2013
Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalinPhilip J Mease, Mildred V Farmer, Robert H Palmer, et al.
Therapeutic Advances in Musculoskeletal Disease|June 2, 2016
Bone repair with skeletal stem cells: rationale, progress to date and clinical applicationElena A Jones, Peter V Giannoudis, Dimitrios Kouroupis
Therapeutic Advances in Musculoskeletal Disease|June 2, 2016
Cardiovascular risk in rheumatoid arthritis: assessment, management and next stepsThomas Zegkos, George Kitas, Theodoros Dimitroulas
Therapeutic Advances in Musculoskeletal Disease|April 6, 2016
Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot studyCarlo Bottegoni, Luca Dei Giudici, Sergio Salvemini, et al.
Therapeutic Advances in Musculoskeletal Disease|December 30, 2024
Impact of obesity on clinical outcomes and treatment continuation in rheumatoid arthritis patients receiving non-TNF-targeted therapiesDong-Jin Park, Hyemin Jeong, Sung-Eun Choi, et al.
Therapeutic Advances in Musculoskeletal Disease|December 2, 2024
Early-stage hypertension defined by the 2017 ACC/AHA blood pressure guideline carries excessive cardiovascular risk in axial spondyloarthritis patientsLin-Hong Shi, Ho So, Steven Ho Man Lam, et al.
Pageof 79